-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
September 09, 2014 - risk assessments were not systematically reviewed for this recommendation, a pragmatic approach is described
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthful-diet-and-physical-activity-for-cardiovascular-disease-prevention-in-adults-without-known-risk-factors-behavioral-counseling-july-2017
July 11, 2017 - Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/depression-in-children-and-adolescents-screening
February 08, 2016 - Authors followed the policy regarding conflicts of interest described at www.uspreventiveservicestaskforce.org
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/family-violence-screening-interventions-1996
January 01, 1996 - Physical findings suggestive of abuse noted during routine or symptomatic examinations have been described
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Lm94jySKCYrG3zsUP8Jd8E
February 16, 2016 - Authors followed the policy regarding conflicts
of interest described at http://www
.uspreventiveservicestaskforce.org
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/gWJU-ZynehGyLBVYtDmMow
May 01, 2009 - in pregnancy or congenital
syphilis: 48
Inappropriate study type: 45
No relevant health outcomes described
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/aD-Br2oTJ67FeNdHHkLtPA
These do not need to undergo the full procedure described above, but should include an
expert bi-lingual
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/from-topic-nomination-to-clinical-practice-resources-overview.pdf
June 01, 2021 - From Topic Nomination to Clinical Practice: Making a Task Force Recommendation
From Topic Nomination to Clinical Practice:
Making a Task Force Recommendation
An Overview of Task Force Processes and Methods
June 2021
How to Read This Presentation
This presentation gives an overview of the processes and metho…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Yc24U4wMLXGoqE5NjwRVA6
April 17, 2018 - 22 or both women and
men (3 RCTs).15-18 The doses and comparators used are similar to
what has been described
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breastfeeding-primary-care-interventions-october-2016
October 25, 2016 - definition of breastfeeding initiation, any breastfeeding, and exclusive breastfeeding was noted as described
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/sexually-transmitted-infections-behavioral-counseling-september-2014
September 22, 2014 - In contrast, one of the studies in our review specifically described their patient population as having
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
April 11, 2016 - We found few data on the effect of treatment duration; 67 , 68 our findings are described in detail … Details are described in the full reports. 12 , 13
Return to Table of Contents
Discussion
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Nvjr8BPsZhy4XGc7-rGjAH
June 18, 2018 - USPSTF approach to the use of model-based analysis as
a complement to systematic evidence reviews is described … Authors
followed the policy regarding conflicts of interest
described at https://www
.uspreventiveservicestaskforce.org
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/B-qVy6dbC25L-KAR5GvLpw
January 01, 2010 - When multiple
articles described the same study, we used the most
complete article as the main source … Many interventions were not
described in sufficient detail to determine with
certainty the absence or
-
www.uspreventiveservicestaskforce.org/uspstf/document/modeling-study/colorectal-cancer-screening-june-2016
June 15, 2016 - These components are described briefly below and in more detail in a full report to the USPSTF 12 ( … strategies with the selection of colonoscopy with a 10-year interval as the benchmark strategy are described
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/UPu84CV2CNuxR8kpVU6e3V
November 01, 2008 - Both models are described
below.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evaluating-test-strategies-for-colorectal-cancer-screening-a-decision-analysis-for-the-us-preventive-services-task-force/colorectal-cancer-screening-2008
October 15, 2008 - Both models are described below.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/aSTzfuKHZtT8_PjfJjuck5
March 01, 2013 - As described by the CDC, IPV should be consid-
ered by using a socioecologic model, based on 4 specific
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/shared-decision-making-about-screening-and-chemoprevention
January 01, 2017 - screening and chemoprevention, clinicians can facilitate this type of decisionmaking using the techniques described
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydial-infection-screening-2001
January 01, 2001 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Recommendations and Rationale
Chlamydial Infection: Screening, 2001
January 01, 2001
Recommendations made by the USPSTF are independent of the U.S. government.…